These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 9290699)

  • 1. Polymerase chain reaction-single-strand conformation polymorphism analysis for the VHL gene in chemically induced kidney tumors of rats using intron-derived primers.
    Shiao YH; Diwan BA; Perantoni AO; Calvert RJ; Zbar B; Lerman MI; Rice JM
    Mol Carcinog; 1997 Aug; 19(4):230-5. PubMed ID: 9290699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of von Hippel-Lindau disease gene mutations in paraffin-embedded sporadic renal cell carcinoma specimens.
    Zhuang Z; Gnarra JR; Dudley CF; Zbar B; Linehan WM; Lubensky IA
    Mod Pathol; 1996 Aug; 9(8):838-42. PubMed ID: 8871925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genomic organization and chromosomal localization of the human CUL2 gene and the role of von Hippel-Lindau tumor suppressor-binding protein (CUL2 and VBP1) mutation and loss in renal-cell carcinoma development.
    Clifford SC; Walsh S; Hewson K; Green EK; Brinke A; Green PM; Gianelli F; Eng C; Maher ER
    Genes Chromosomes Cancer; 1999 Sep; 26(1):20-8. PubMed ID: 10441001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Somatic mutations of the von Hippel-Lindau tumor suppressor gene in sporadic central nervous system hemangioblastomas.
    Kanno H; Kondo K; Ito S; Yamamoto I; Fujii S; Torigoe S; Sakai N; Hosaka M; Shuin T; Yao M
    Cancer Res; 1994 Sep; 54(18):4845-7. PubMed ID: 8069849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequent somatic mutations and loss of heterozygosity of the von Hippel-Lindau tumor suppressor gene in primary human renal cell carcinomas.
    Shuin T; Kondo K; Torigoe S; Kishida T; Kubota Y; Hosaka M; Nagashima Y; Kitamura H; Latif F; Zbar B
    Cancer Res; 1994 Jun; 54(11):2852-5. PubMed ID: 8187067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutation of the VHL gene is associated exclusively with the development of non-papillary renal cell carcinomas.
    Kenck C; Wilhelm M; Bugert P; Staehler G; Kovacs G
    J Pathol; 1996 Jun; 179(2):157-61. PubMed ID: 8758207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low incidence of point mutations detected in the p53 tumor suppressor gene from chemically induced rat renal mesenchymal tumors.
    Weghorst CM; Dragnev KH; Buzard GS; Thorne KL; Vandeborne GF; Vincent KA; Rice JM
    Cancer Res; 1994 Jan; 54(1):215-9. PubMed ID: 8261441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential regulation of c-fos expression in estrogen-induced hamster renal tumors compared with kidney not due to creation of an estrogen-response element by point mutation in the gene's flanking sequence.
    Sarabia SF; Liehr JG
    Mol Carcinog; 1999 Apr; 24(4):255-62. PubMed ID: 10326862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal cell carcinoma development in the rat independent of alterations at the VHL gene locus.
    Walker C; Ahn YT; Everitt J; Yuan X
    Mol Carcinog; 1996 Feb; 15(2):154-61. PubMed ID: 8599582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. von Hippel-Lindau gene mutations in N-nitrosodimethylamine-induced rat renal epithelial tumors.
    Shiao YH; Rice JM; Anderson LM; Diwan BA; Hard GC
    J Natl Cancer Inst; 1998 Nov; 90(22):1720-3. PubMed ID: 9827526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutations in the VHL gene from potassium bromate-induced rat clear cell renal tumors.
    Shiao YH; Kamata SI; Li LM; Hooth MJ; DeAngelo AB; Anderson LM; Wolf DC
    Cancer Lett; 2002 Dec; 187(1-2):207-14. PubMed ID: 12359370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of the von Hippel-Lindau gene deletion in cytologic specimens using microdissection and the polymerase chain reaction.
    Zhuang Z; Roth MJ; Emmert-Buck MR; Lubensky IA; Liotta LA; Solomon D
    Acta Cytol; 1994; 38(5):671-5. PubMed ID: 8091895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retinoblastoma gene mutation in primary human renal cell carcinoma.
    Shuin T; Torigoe S; Kubota Y; Kishida T; Hosaka M; Horikoshi T; Yao M; Kondo K; Sakai N; Danenberg K
    Oncol Res; 1995; 7(2):63-6. PubMed ID: 7579728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Establishment of experimental conditions for the rapid detection of mutations in the von Hippel-Lindau gene by parallel temperature gradient gel electrophoresis.
    Hernández A; Meyer A; Enczmann J; Ackermann R; Wernet P
    Electrophoresis; 1999 Jul; 20(10):1958-61. PubMed ID: 10451103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Down-regulation of von Hippel-Lindau protein in N-nitroso compound-induced rat non-clear cell renal tumors.
    Shiao YH; Ramakrishna G; Anderson LM; Perantoni AO; Rice JM; Diwan BA
    Cancer Lett; 2002 May; 179(1):33-8. PubMed ID: 11880179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associations between VHL genotype and clinical phenotype in familial von Hippel-Lindau disease.
    Huang JS; Huang CJ; Chen SK; Chien CC; Chen CW; Lin CM
    Eur J Clin Invest; 2007 Jun; 37(6):492-500. PubMed ID: 17537157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multifocal bilateral renal cell carcinoma and retinal angiomas in a patient with de novo von Hippel-Lindau disease: identification of a new germline mutation.
    Sessa A; Battini G; Meroni M; Pitingolo F; Righetti M; Ciotti P; Di Maria E; Bellone E; Ajmar F; Mandich P
    J Nephrol; 2005; 18(2):209-12. PubMed ID: 15931650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Somatic mutation of the tuberous sclerosis (Tsc2) tumor suppressor gene in chemically induced rat renal carcinoma cell.
    Urakami S; Tokuzen R; Tsuda H; Igawa M; Hino O
    J Urol; 1997 Jul; 158(1):275-8. PubMed ID: 9186374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cloning of the rat homologue of the von Hippel-Lindau tumor suppressor gene and its non-somatic mutation in rat renal cell carcinomas.
    Kikuchi Y; Kobayashi E; Nishizawa M; Hamazaki S; Okada S; Hino O
    Jpn J Cancer Res; 1995 Oct; 86(10):905-9. PubMed ID: 7493907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allelic deletion and mutation of the von Hippel-Lindau (VHL) tumor suppressor gene in pancreatic microcystic adenomas.
    Vortmeyer AO; Lubensky IA; Fogt F; Linehan WM; Khettry U; Zhuang Z
    Am J Pathol; 1997 Oct; 151(4):951-6. PubMed ID: 9327728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.